𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pseudotumor Cerebri Caused by All-Trans-Retinoic Acid Treatment for Acute Promyelocytic Leukemia

✍ Scribed by Yu-Chen Yeh; Huei-Fen Tang; I-Mo Fang

Publisher
Springer
Year
2006
Tongue
English
Weight
245 KB
Volume
50
Category
Article
ISSN
0021-5155

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

ALL-TRANS RETINOIC ACID (ATRA) IN THE TR
ALL-TRANS RETINOIC ACID (ATRA) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL)
✍ C. S. CHIM; Y. L. KWONG; R. LIANG; Y. C. CHU; C. H. CHAN; L. C. CHAN; K. F. WONG πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 498 KB πŸ‘ 2 views

Acute promyelocytic leukemia is characterized by the reciprocal translocation of chromosomes 15 and 17. All-trans retinoic acid (ATRA) efficiently induces differentiation of the abnormal promyelocytes. In this study, we had used ATRA as the primary induction therapy for 17 newly diagnosed patients,

Pharmacology of all-trans-retinoic acid
Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia
✍ Lanvers, Claudia ;Reinhardt, Dirk ;DΓΌbbers, Angelika ;Wagner-Bohn, Alexandra ;Cr πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 158 KB πŸ‘ 1 views

## Abstract ## Background Due to severe side effects in virtually all children treated with a standard dose of 45 mg/m^2^/day all‐__trans__‐retinoic acid (ATRA) for acute promyelocytic leukemia (APL) the AML‐BFM study group reduced the dosage to 25 mg/m^2^/day. For the lack of data on the use of A